Overview

Bone Graft Substitutes Market is poised to value over USD 3.5 billion by 2027 end at a CAGR of over 3% during the forecast period 2020 to 2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Bone Graft Substitutes Market  trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Bone Graft Substitutes Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Bone Graft Substitutes Market:
• NovaBone Product, LLC.
• Exactech, Inc.
• Medtronic Plc.
• LifeNet Health
• Zimmer Biomet Holdings, Inc.
• Stryker Corporation.
• BioHorizons Implant Systems, Inc.
• Globus Medical, Inc.
• RTI Surgical, Inc
• Geistlich Pharma
• Megagen
• Novadip Biosciences
• Mesoblast Ltd.
• Alphatec Spine, Inc.
• Institut Straumann AG
• NuVasive, Inc.
• OsteoMed LLC
• KYERON Medical Innovations
(Note: The list of the major players will be updated with the latest market scenario and trends)

Bone Graft Substitutes Market Segmentation:
By Product
• Allografts
• Demineralized Bone Matrix (DBM)
• Synthetic Bone Graft
     o Polymer
     o Ceramic
           o Hydroxyapatite
           o Beta TCP
• Xenograft
• Autograft
By Material
• Ceramic-based
   o Calcium Phosphate
   o Calcium Sulfate
• Polymer-based
   o Polylactides
   o Polyglycolides
   o Polyurethanes
   o Others
• Growth Factor-based
• Cell-based
• Others
By Application
• Craniomaxillofacial
• Dental
• Foot & Ankle
• Joint Reconstruction
• Spinal Fusion
• Long Bones
• Others
By End User
• Hospitals
• Clinics
• Ambulatory Care Centers
• Academic & Research Institutes
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Bone Graft Substitutes Market By Product, By Material, By Application, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- Product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Global Bone Graft Substitutes Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Bone Graft Substitutes Market Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Bone Graft Substitutes Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Global Bone Graft Substitutes Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
  7.1. Allografts
  7.2. Demineralized Bone Matrix (DBM)
  7.3. Synthetic Bone Graft
         7.3.1. Polymer
         7.3.2. Ceramic
                   7.3.2.1. Hydroxyapatite
                   7.3.2.2. Beta TCP
  7.4. Xenograft
  7.5. Autograft

8. Global Bone Graft Substitutes Market, By Material Historical Analysis and Forecast 2020-2027 (USD Million)
  8.1. Ceramic-based
       8.1.1. Calcium Phosphate
       8.1.2. Calcium Sulfate
  8.2. Polymer-based
       8.2.1. Polylactides
       8.2.2. Polyglycolides
       8.2.3. Polyurethanes
       8.2.4. Others
  8.3. Growth Factor-based
  8.4. Cell-based
  8.5. Others

9. Global Bone Graft Substitutes Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
  9.1. Craniomaxillofacial
  9.2. Dental
  9.3. Foot & Ankle
  9.4. Joint Reconstruction
  9.5. Spinal Fusion
  9.6. Long Bones
  9.7. Others

10. Global Bone Graft Substitutes Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
   10.1. Hospitals
   10.2. Clinics
   10.3. Ambulatory Care Centers
   10.4. Academic & Research Institutes

11. North America Bone Graft Substitutes Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
  11.1. Introduction
  11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
       11.2.1. U.S.A
       11.2.2. Canada
       11.2.3. Mexico
  11.3. Market Size (USD Million) Forecast for North America 2020-2027

12. Latin America Bone Graft Substitutes Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   12.1. Introduction
   12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         12.2.1. Brazil
         12.2.2. Venezuela
         12.2.3. Argentina
         12.2.4. Rest of Latin America
   12.3. Market Size (USD Million) Forecast for Latin America 2020-2027

13. Europe Bone Graft Substitutes Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   13.1. Introduction
   13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         13.2.1. Germany
         13.2.2. U.K        
         13.2.3. France
         13.2.4. Italy
         13.2.5. Spain
         13.2.6. Russia
         13.2.7. Poland
         13.2.8. Rest of Europe
   13.3. Market Size (USD Million) Forecast for Europe 2020-2027

14. Asia Pacific Bone Graft Substitutes Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   14.1. Introduction
   14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         14.2.1. Japan
         14.2.2. China
         14.2.3. India
         14.2.4. Australia and New Zealand
         14.2.5. ASEAN
         14.2.6. Rest of Asia Pacific
   14.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027  

15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   15.1. Introduction
   15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         15.2.1. Saudi Arabia
         15.2.2. UAE
         15.2.3. South Africa
         15.2.4. Egypt
   15.3. Market Size (USD Million) Forecast for MEA 2020-2027

16. Market Share Analysis and Competitive Landscape  
   16.1. Global Landscape - Key Players, Revenue and Presence
   16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   16.3. Global Emerging Companies
   16.4. North America - Market Share Analysis and Key Regional Players
   16.5. Europe - Market Share Analysis and Key Regional Players
   16.6. Asia Pacific - Market Share Analysis and Key Regional Players
   16.7. Global Key Player - Growth Matrix

17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   17.1. NovaBone Product, LLC.
         17.1.1. Company Overview
         17.1.2. Product Portfolio
         17.1.3. SWOT Analysis
         17.1.4. Financial Overview
         17.1.5. Strategic Overview
   17.2. Exactech, Inc.
         17.2.1. Company Overview
         17.2.2. Product Portfolio
         17.2.3. SWOT Analysis
         17.2.4. Financial Overview
         17.2.5. Strategic Overview
   17.3. Medtronic Plc.
         17.3.1. Company Overview
         17.3.2. Product Portfolio
         17.3.3. SWOT Analysis
         17.3.4. Financial Overview
         17.3.5. Strategic Overview
   17.4. LifeNet Health
         17.4.1. Company Overview
         17.4.2. Product Portfolio
         17.4.3. SWOT Analysis
         17.4.4. Financial Overview
         17.4.5. Strategic Overview
   17.5. Zimmer Biomet Holdings, Inc.
         17.5.1. Company Overview
         17.5.2. Product Portfolio
         17.5.3. SWOT Analysis
         17.5.4. Financial Overview
         17.5.5. Strategic Overview          
   17.6. Stryker Corporation.
         17.6.1. Company Overview
         17.6.2. Product Portfolio
         17.6.3. SWOT Analysis
         17.6.4. Financial Overview
         17.6.5. Strategic Overview      
   17.7. BioHorizons Implant Systems, Inc.
         17.7.1. Company Overview
         17.7.2. Product Portfolio
         17.7.3. SWOT Analysis
         17.7.4. Financial Overview
         17.7.5. Strategic Overview
   17.8. Globus Medical, Inc.
         17.8.1. Company Overview
         17.8.2. Product Portfolio
         17.8.3. SWOT Analysis
         17.8.4. Financial Overview
         17.8.5. Strategic Overview
   17.9. RTI Surgical, Inc
         17.9.1. Company Overview
         17.9.2. Product Portfolio
         17.9.3. SWOT Analysis
         17.9.4. Financial Overview
         17.9.5. Strategic Overview
   17.10.Geistlich Pharma
         17.10.1.Company Overview
         17.10.2.Product Portfolio
         17.10.3.SWOT Analysis
         17.10.4.Financial Overview
         17.10.5.Strategic Overview
   17.11.Megagen
         17.11.1.Company Overview
         17.11.2.Product Portfolio
         17.11.3.SWOT Analysis
         17.11.4.Financial Overview
         17.11.5.Strategic Overview
   17.12.Novadip Biosciences
         17.12.1.Company Overview
         17.12.2.Product Portfolio
         17.12.3.SWOT Analysis
         17.12.4.Financial Overview
         17.12.5.Strategic Overview
   17.13.Mesoblast Ltd.
         17.13.1.Company Overview
         17.13.2.Product Portfolio
         17.13.3.SWOT Analysis
         17.13.4.Financial Overview
         17.13.5.Strategic Overview
   17.14.Alphatec Spine, Inc.
         17.14.1.Company Overview
         17.14.2.Product Portfolio
         17.14.3.SWOT Analysis
         17.14.4.Financial Overview
         17.14.5.Strategic Overview
   17.15.Institut Straumann AG
         17.15.1.Company Overview
         17.15.2.Product Portfolio
         17.15.3.SWOT Analysis
         17.15.4.Financial Overview
         17.15.5.Strategic Overview
   17.16.NuVasive, Inc.
         17.16.1.Company Overview
         17.16.2.Product Portfolio
         17.16.3.SWOT Analysis
         17.16.4.Financial Overview
         17.16.5.Strategic Overview
   17.17.OsteoMed LLC
         17.17.1.Company Overview
         17.17.2.Product Portfolio
         17.17.3.SWOT Analysis
         17.17.4.Financial Overview
         17.17.5.Strategic Overview
   17.18.KYERON Medical Innovations
         17.18.1.Company Overview
         17.18.2.Product Portfolio
         17.18.3.SWOT Analysis
         17.18.4.Financial Overview
         17.18.5.Strategic Overview

18. Pre and Post COVID-19 Impact
   18.1. Positive influence on the healthcare industry
   18.2. The financial disruption of the manufacturing sector
   18.3. Impact of COVID-19 on emerging companies
   18.4. Significant mandates in the healthcare regulations initiated by administrations
   18.5. The overall economic slowdown of the developing and developed nations

19. FutureWise SME Key Takeaway Points for Client

Tables

Figures